Navigation Links
IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
Date:11/15/2011

MOUNTAIN VIEW, Calif., Nov. 15, 2011 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) announced it has entered into a license and distribution agreement with Alcon, the global leader in eye care, headquartered in Fort Worth, Texas.  The agreement covers the IRIDEX GreenTip™ Soft Tip Cannula family of products and license rights to the associated patented technology.  

IRIDEX GreenTip Soft Tip Cannula products are used in vitrectomy procedures and allow retina surgeons to effectively visualize and access the proximity of the retina. Benefits include: optimal contrast against the retina, maximized visualization and greater protection of the retina with its unique atraumatic silicone tip.

As part of the agreement, Alcon will pay $1.5 million in upfront royalties to IRIDEX, purchase IRIDEX branded products for distribution in the U.S. and pay an ongoing royalty to license and manufacture related Alcon branded products for distribution overseas.

"An important part of our growth strategy is to develop and identify unique consumable products that bring clinical value to retina surgeons and their patients, and we are very pleased to be working with Alcon in distributing a key product family in that category," commented Dr. Dominik Beck, President & CEO. "Working with Alcon, the market leader in ophthalmology devices, underscores the value of our enhanced visualization cannula products and may lead to additional opportunities for collaboration in the future."

About IRIDEX Corporation

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
2. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
3. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
4. IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO
5. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
6. IRIDEX Expands ENT Laser Applications
7. IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter
8. IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
9. IRIDEX Announces First Quarter 2011 Conference Call and Release Date
10. IRIDEX to Present at the Roth OC Growth Stock Conference in Dana Point, CA
11. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 Shire plc ... waived the Office of Fair Trading (OFT) approval condition to the ... Incorporated (NASDAQ: VPHM).   As a result of the ... Shire expects to complete the tender offer on January 24, 2014 ...
(Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... EAST SETAUKET, N.Y., Dec. 19, 2011  An article in the ... of the National Academy of Sciences USA , reported ... therapeutic potential in a laboratory model of Gaucher disease  ... and president of Lixte said, "This is a novel ...
... MISSISSAUGA, Ontario, Dec. 19, 2011  Valeant Pharmaceuticals International, ... VRX) announced that effective December 16, 2011, the ... a dermatology unit of Sanofi (EURONEXT: SAN and ... International, Inc. Valeant Pharmaceuticals International, ...
Cached Medicine Technology:Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 2Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 3
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... review published in the April issue of Immunity ... Institute for Medical Research, says it,s time to take ... to treating sepsis, which kills millions worldwide every ... when molecules released into the bloodstream to fight an ... is necessary for maintaining good health without inflammation, ...
(Date:4/17/2014)... 2014U.S. military personnel who served in Iraq and ... brain injury (TBI) were compared to military personnel ... reasons. Differences in measures of overall disability, cognitive ... injury are reported in an article in ... Mary Ann Liebert, Inc., publishers. The article is ...
(Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2
... prevailing trend among kids of today, who have turned ... options.// ,Researchers from university of waterloo conducted ... about eating wrong from a tender age. Parents ... which is a leading cause of increasing obesity rates, ...
... number of tuberculosis cases detected annually in Thailand ... Nation reports.// ,According to Somchai Pinyopornpaitch, ... TB cases have increased for several years despite ... currently 50 per 100,000 people, with 90,000 new ...
... the go-ahead to the new cosmetic filler, Radiesse, to ... in patients with AIDS or HIV. This calcium based ... collagen. ,To ascertain the potential benefits of ... HIV patients suffering facial lipoatrophy. The patients were given ...
... called as ‘Mindfulness’ is now being taught to Queensland women ... solution for women who struggle with binge eating and bulimia. ... with the emotions that trigger their binges. ... on food and controlling eating and more on providing freedom ...
... a simple equation; more guns, more murders. ,In ... School of Public Health came out with results of a ... is a hot topic in US, where the case for ... US households owns a gun,according to current data. ...
... on the surprise findings of a study appearing in the ... that scientists have discovered histamine,// the inflammatory compound released during ... ,They say that histamine can be produced ... Blood Cells (WBC) that is the major component of pus. ...
Cached Medicine News:Health News:WBC in Lung Produces Histamine: Study 2Health News:WBC in Lung Produces Histamine: Study 3
... refrigerated multifunction centrifuges are equally capable of high ... sound level with a large range of rotors ... exchange system without tools ensures that the required ... Instant rotor exchange (5 sec.) with ...
... Drug Discovery, Biotechnology, Genomic and ... special Quality Control over Sample Preparation ... an advanced benchtop ventilated centrifuge accommodates ... high capacity production throughput. High throughput ...
... A common sight in laboratories everywhere, ... rugged, dependable centrifuge standards for decades ... The Model K's simple, classic design ... it a standard for centrifuge performance, ...
Inquire...
Medicine Products: